Dolby Laboratories, Inc. (DLB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 09-26. Amounts in USD.

Revenue TTM

0 500M 1B 1.5B Q4 '21: 1.3B Q1 '22: 1.2B Q3 '22: 1.3B Q4 '22: 1.3B Q4 '22: 1.3B Q1 '23: 1.2B Q2 '23: 1.3B Q3 '23: 1.3B Q4 '23: 1.3B Q1 '24: 1.3B Q2 '24: 1.3B Q3 '24: 1.3B Q4 '24: 1.3B Q1 '25: 1.3B Q2 '25: 1.3B Q3 '25: 1.3B Q4 '25: 1.3B Q1 '26: 1.3B Q2 '26: 1.4B Q3 '26: 1.4B Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Gross Profit TTM

0 500M 1B 1.5B Q4 '21: 1.2B Q1 '22: 1.1B Q3 '22: 1.1B Q4 '22: 1.1B Q4 '22: 1.1B Q1 '23: 1.1B Q2 '23: 1.1B Q3 '23: 1.1B Q4 '23: 1.1B Q1 '24: 1.1B Q2 '24: 1.1B Q3 '24: 1.1B Q4 '24: 1.1B Q1 '25: 1.2B Q2 '25: 1.2B Q3 '25: 1.2B Q4 '25: 1.2B Q1 '26: 1.2B Q2 '26: 1.2B Q3 '26: 1.2B Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating Income TTM

0 150M 300M 450M Q4 '21: 344.4M Q1 '22: 270.2M Q3 '22: 230.4M Q4 '22: 219.9M Q4 '22: 206.6M Q1 '23: 210.1M Q2 '23: 276M Q3 '23: 246.4M Q4 '23: 215.8M Q1 '24: 187.9M Q2 '24: 187.6M Q3 '24: 208.5M Q4 '24: 258.3M Q1 '25: 272M Q2 '25: 270.8M Q3 '25: 281.6M Q4 '25: 265M Q1 '26: 247.2M Q2 '26: 252.4M Q3 '26: 239.1M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Net Income TTM

0 150M 300M 450M Q4 '21: 310.2M Q1 '22: 255M Q3 '22: 215.5M Q4 '22: 200.5M Q4 '22: 184.1M Q1 '23: 183.4M Q2 '23: 242.4M Q3 '23: 219.2M Q4 '23: 200.7M Q1 '24: 188.3M Q2 '24: 190.4M Q3 '24: 212.4M Q4 '24: 261.8M Q1 '25: 262.7M Q2 '25: 256.6M Q3 '25: 264.3M Q4 '25: 255M Q1 '26: 240.5M Q2 '26: 243.6M Q3 '26: 226.2M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Cost of Revenue TTM

0 60M 120M 180M Q4 '21: 130M Q1 '22: 127.4M Q3 '22: 130.6M Q4 '22: 134.9M Q4 '22: 141.4M Q1 '23: 143.1M Q2 '23: 148.6M Q3 '23: 154.2M Q4 '23: 152.6M Q1 '24: 150.2M Q2 '24: 147.9M Q3 '24: 142.1M Q4 '24: 140.5M Q1 '25: 149.2M Q2 '25: 146.3M Q3 '25: 154.6M Q4 '25: 160.1M Q1 '26: 162.6M Q2 '26: 171.5M Q3 '26: 167.8M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating Cash Flow TTM

0 200M 400M 600M Q4 '21: 447.8M Q1 '22: 397.3M Q3 '22: 376.8M Q4 '22: 377M Q4 '22: 318.6M Q1 '23: 343.3M Q2 '23: 384.9M Q3 '23: 333.4M Q4 '23: 367.1M Q1 '24: 319.1M Q2 '24: 396M Q3 '24: 296.1M Q4 '24: 327.3M Q1 '25: 425.6M Q2 '25: 419.1M Q3 '25: 465.5M Q4 '25: 472.2M Q1 '26: 420.2M Q2 '26: 337.8M Q3 '26: 437.6M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Free Cash Flow TTM

0 150M 300M 450M Q4 '21: 393.3M Q1 '22: 343.9M Q3 '22: 325.2M Q4 '22: 328M Q4 '22: 270.6M Q1 '23: 302.6M Q2 '23: 348.2M Q3 '23: 300.5M Q4 '23: 336.7M Q1 '24: 289.9M Q2 '24: 365.3M Q3 '24: 265.3M Q4 '24: 297.2M Q1 '25: 394.9M Q2 '25: 390.4M Q3 '25: 438.1M Q4 '25: 435.9M Q1 '26: 386M Q2 '26: 301.5M Q3 '26: 392.7M Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q3 '20: 102.1M Q4 '20: 102.7M Q1 '21: 103.9M Q2 '21: 104.6M Q3 '21: 104.6M Q1 '22: 103.8M Q3 '22: 102.7M Q4 '22: 101.5M Q1 '23: 97M Q2 '23: 97.3M Q3 '23: 97.5M Q1 '24: 97.4M Q2 '24: 96.9M Q3 '24: 97M Q1 '25: 97.1M Q2 '25: 97.5M Q3 '25: 96.9M Q1 '26: 96.5M Q2 '26: 95.5M Q3 '26: 94.5M Q4 '20 Q3 '21 Q4 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.50 3.00 4.50 Q4 '21: 2.98 Q1 '22: 2.45 Q3 '22: 2.08 Q4 '22: 1.95 Q4 '22: 1.81 Q1 '23: 1.86 Q2 '23: 2.48 Q3 '23: 2.26 Q4 '23: 2.06 Q1 '24: 1.93 Q2 '24: 1.96 Q3 '24: 2.19 Q4 '24: 2.70 Q1 '25: 2.71 Q2 '25: 2.64 Q3 '25: 2.72 Q4 '25: 2.63 Q1 '26: 2.48 Q2 '26: 2.53 Q3 '26: 2.35 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.